These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9541080)

  • 41. Fecal occult blood screening for colorectal cancer.
    Van Dam J; Bond JH; Sivak MV
    Arch Intern Med; 1995 Dec 11-25; 155(22):2389-402. PubMed ID: 7503597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colorectal cancer screening in Italy: feasibility and cost-effectiveness in a model area.
    Sorrentino D; Paduano R; Bernardis V; Piccolo A; Bartoli E
    Eur J Gastroenterol Hepatol; 1999 Jun; 11(6):655-60. PubMed ID: 10418938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness of colorectal cancer screening.
    Donohoe M
    JAMA; 2001 Jan 24-31; 285(4):407; author reply 408. PubMed ID: 11242412
    [No Abstract]   [Full Text] [Related]  

  • 45. Cost-effectiveness of screening for colorectal cancer: a simulation model.
    Neilson AR; Whynes DK
    IMA J Math Appl Med Biol; 1995; 12(3-4):355-67. PubMed ID: 8919570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colorectal cancer screening is cost-effective, OTA study shows.
    Oncology (Williston Park); 1996 May; 10(5):665. PubMed ID: 8738822
    [No Abstract]   [Full Text] [Related]  

  • 47. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mass screening for colorectal cancer].
    Faivre J; Tazi MA; Launoy G
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S7-14. PubMed ID: 8935859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Colorectal cancer in Germany. Means for prevention and early detection: implications for laiety and physicians].
    Eickhoff A; Maar C; Birkner B; Riemann JF
    Internist (Berl); 2003 Mar; 44(3):278, 281-6. PubMed ID: 12731414
    [No Abstract]   [Full Text] [Related]  

  • 50. Costs of screening for colorectal cancer: an Australian programme.
    Gow J
    Health Econ; 1999 Sep; 8(6):531-40. PubMed ID: 10544318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for colorectal cancer by immunochemical fecal occult blood testing.
    Saito H
    Jpn J Cancer Res; 1996 Oct; 87(10):1011-24. PubMed ID: 8957057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Faecal occult blood testing in the secondary prevention of colorectal cancer.
    Kronborg O
    Eur J Cancer Prev; 2001 Apr; 10(2):167-8. PubMed ID: 11330459
    [No Abstract]   [Full Text] [Related]  

  • 53. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler B; Irwig L; Glasziou P; Kewenter J; Weller D; Silagy C
    BMJ; 1998 Aug; 317(7158):559-65. PubMed ID: 9721111
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis.
    van Rossum LG; van Rijn AF; Verbeek AL; van Oijen MG; Laheij RJ; Fockens P; Jansen JB; Adang EM; Dekker E
    Int J Cancer; 2011 Apr; 128(8):1908-17. PubMed ID: 20589677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fecal occult blood testing for colorectal cancer. Can we afford to do this?
    Ahlquist DA
    Gastroenterol Clin North Am; 1997 Mar; 26(1):41-55. PubMed ID: 9119439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Costs and effects of alternative screening programs against cervical cancer].
    Gyrd-Hansen D; Hølund B; Andersen P
    Ugeskr Laeger; 1996 Aug; 158(35):4912-5. PubMed ID: 8801698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colorectal cancer screening: clinical applications.
    Walsh JM; Terdiman JP
    JAMA; 2003 Mar; 289(10):1297-302. PubMed ID: 12633192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
    Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost Effectiveness of Colorectal Cancer Screening Interventions with Their Effects on Health Disparity Being Considered.
    Lee KS; Park EC
    Cancer Res Treat; 2016 Jul; 48(3):1010-9. PubMed ID: 26727714
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.